ProCE Banner Activity

ExpressPoints: New Advances in Follicular Lymphoma: A Focus on the Expanding Role of PI3K Inhibitors

Slideset Download
Download this brief summary slideset of key takeaway points from a live presentation on PI3K inhibitors in the treatment of follicular lymphoma.

Released: June 18, 2021

Expiration: June 17, 2022

No longer available for credit.

Share

Faculty

John M. Burke

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Nathan H. Fowler

Nathan H. Fowler, MD

Associate Professor
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

TG Therapeutics

Faculty Disclosure

Primary Author

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Nathan H. Fowler, MD

Associate Professor
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas